Both ATP sites of human P-glycoprotein are essential but not symmetric

Biochemistry. 1999 Oct 19;38(42):13887-99. doi: 10.1021/bi991115m.

Abstract

Human P-glycoprotein (P-gp) is a cell surface drug efflux pump that contains two nucleotide binding domains (NBDs). Mutations were made in each of the Walker B consensus motifs of the NBDs at positions D555N and D1200N, thought to be involved in Mg(2+) binding. Although the mutant and wild-type P-gps were expressed equivalently at the cell surface and bound the drug analogue [(125)I]iodoarylazidoprazosin ([(125)I]IAAP) comparably, neither of the mutant proteins was able to transport fluorescent substrates nor had detectable basal nor drug-stimulated ATPase activities. The wild-type and D1200N P-gps were labeled comparably with [alpha-(32)P]-8-azido-ATP at a subsaturating concentration of 2.5 microM, whereas labeling of the D555N mutant was severely impaired. Mild trypsin digestion, to cleave the protein into two halves, demonstrated that the N-half of the wild-type and D1200N proteins was labeled preferentially with [alpha-(32)P]-8-azido-ATP. [alpha-(32)P]-8-Azido-ATP labeling at 4 degrees C was inhibited in a concentration-dependent manner by ATP with half-maximal inhibition at approximately 10-20 microM for the P-gp-D1200N mutant and wild-type P-gp. A chimeric protein containing two N-half NBDs was found to be functional for transport and was also asymmetric with respect to [alpha-(32)P]-8-azido-ATP labeling, suggesting that the context of the ATP site rather than its exact sequence is an important determinant for ATP binding. By use of [alpha-(32)P]-8-azido-ATP and vanadate trapping, it was determined that the C-half of wild-type P-gp was labeled preferentially under hydrolysis conditions; however, the N-half was still capable of being labeled with [alpha-(32)P]-8-azido-ATP. Neither mutant was labeled under vanadate trapping conditions, indicating loss of ATP hydrolysis activity in the mutants. In confirmation of the lack of ATP hydrolysis, no inhibition of [(125)I]IAAP labeling was observed in the mutants in the presence of vanadate. Taken together, these data suggest that the two NBDs are asymmetric and intimately linked and that a conformational change in the protein may occur upon ATP hydrolysis. Furthermore, these data are consistent with a model in which binding of ATP to one site affects ATP hydrolysis at the second site.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / antagonists & inhibitors
  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / chemistry*
  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / genetics
  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / immunology
  • Adenosine Triphosphatases / metabolism
  • Adenosine Triphosphate / analogs & derivatives
  • Adenosine Triphosphate / metabolism*
  • Amino Acid Motifs / drug effects
  • Amino Acid Motifs / genetics
  • Amino Acid Substitution / genetics
  • Antibodies, Monoclonal / metabolism
  • Asparagine / genetics
  • Aspartic Acid / genetics
  • Azides / antagonists & inhibitors
  • Azides / metabolism
  • Binding Sites / genetics
  • Biological Transport / drug effects
  • Biological Transport / genetics
  • Body Temperature
  • Cell Membrane / enzymology
  • Cell Membrane / metabolism
  • Consensus Sequence / drug effects
  • Consensus Sequence / genetics
  • Enzyme Activation / drug effects
  • Freezing
  • HeLa Cells
  • Humans
  • Peptide Fragments / chemistry
  • Peptide Fragments / genetics
  • Peptide Fragments / metabolism
  • Phosphorus Radioisotopes / metabolism
  • Photoaffinity Labels / metabolism
  • Point Mutation
  • Prazosin / analogs & derivatives
  • Prazosin / antagonists & inhibitors
  • Prazosin / metabolism
  • Protein Conformation
  • Recombinant Fusion Proteins / biosynthesis
  • Recombinant Fusion Proteins / genetics
  • Recombinant Fusion Proteins / metabolism
  • Vanadates / pharmacology
  • Verapamil / pharmacology

Substances

  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Antibodies, Monoclonal
  • Azides
  • Peptide Fragments
  • Phosphorus Radioisotopes
  • Photoaffinity Labels
  • Recombinant Fusion Proteins
  • Aspartic Acid
  • Vanadates
  • 8-azidoadenosine 5'-triphosphate
  • Asparagine
  • Adenosine Triphosphate
  • azidoprazosin
  • Verapamil
  • Adenosine Triphosphatases
  • Prazosin